|
|
News Breaks
|
March 2, 2010
|
| 08:07 EDT |  | AIS |
| theflyonthewall.com: | Antares Pharma completes enrollment for Phase III trial of Anturol | | Antares Pharma announced that it has completed enrollment in the double-blind portion of the ompancy's Phase III clinical trial of Anturol, its transdermal oxybutynin ATD gel for the treatment of overactive bladder. Top line data from this pivotal trial, which is being conducted under a Special Protocol Assessment FDA, is expected in the Q3 of this year. :theflyonthewall.com |
|
|
News For AIS From The Last 14 Days Check below for free stories on AIS the last two weeks.
There are 2 items on the Fly with pertinent information.
Sign up for a free trial to see the rest of the stories you've been missing. |
|
February 1, 2012
|
| 10:33 EDT |  | AIS |
| | 06:27 EDT | | AIS |
|
|
|
|
|
Subscribe for More Information